Trial
NCT05946551
Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
CURE Drug Repurposing Collaboratory (CDRC)
Condition
COVID-19
Intervention
Cetirizine
Why stopped
Study was terminated due to lack of funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-17